Machine learning for the early prediction of infants with electrographic seizures in neonatal hypoxic-ischemic encephalopathy
ANSeR Consortium
(2023) Epilepsia, volume 64, issue 2, pp. 456 - 468
(Article)
Abstract
OBJECTIVE: To assess if early clinical and electroencephalography (EEG) features predict later seizure development in infants with hypoxic-ischemic encephalopathy (HIE). METHODS: Clinical and EEG parameters <12 h of birth from infants with HIE across eight European Neonatal Units were used to develop seizure-prediction models. Clinical parameters included intrapartum complications, fetal distress,
... read more
gestational age, delivery mode, gender, birth weight, Apgar scores, assisted ventilation, cord pH, and blood gases. The earliest EEG hour provided a qualitative analysis (discontinuity, amplitude, asymmetry/asynchrony, sleep-wake cycle [SWC]) and a quantitative analysis (power, discontinuity, spectral distribution, inter-hemispheric connectivity) from full montage and two-channel amplitude-integrated EEG (aEEG). Subgroup analysis, only including infants without anti-seizure medication (ASM) prior to EEG was also performed. Machine-learning (ML) models (random forest and gradient boosting algorithms) were developed to predict infants who would later develop seizures and assessed using Matthews correlation coefficient (MCC) and area under the receiver-operating characteristic curve (AUC). RESULTS: The study included 162 infants with HIE (53 had seizures). Low Apgar, need for ventilation, high lactate, low base excess, absent SWC, low EEG power, and increased EEG discontinuity were associated with seizures. The following predictive models were developed: clinical (MCC 0.368, AUC 0.681), qualitative EEG (MCC 0.467, AUC 0.729), quantitative EEG (MCC 0.473, AUC 0.730), clinical and qualitative EEG (MCC 0.470, AUC 0.721), and clinical and quantitative EEG (MCC 0.513, AUC 0.746). The clinical and qualitative-EEG model significantly outperformed the clinical model alone (MCC 0.470 vs 0.368, p-value .037). The clinical and quantitative-EEG model significantly outperformed the clinical model (MCC 0.513 vs 0.368, p-value .012). The clinical and quantitative-EEG model for infants without ASM (n = 131) had MCC 0.588, AUC 0.832. Performance for quantitative aEEG (n = 159) was MCC 0.381, AUC 0.696 and clinical and quantitative aEEG was MCC 0.384, AUC 0.720. SIGNIFICANCE: Early EEG background analysis combined with readily available clinical data helped predict infants who were at highest risk of seizures, hours before they occur. Automated quantitative-EEG analysis was as good as expert analysis for predicting seizures, supporting the use of automated assessment tools for early evaluation of HIE.
show less
Download/Full Text
Keywords: machine learning, neonatal encephalopathy, neonatal seizures, neonates, prediction algorithm, Neurology, Clinical Neurology
ISSN: 0013-9580
Publisher: Wiley-Blackwell
Note: Funding Information: This study was supported by: A Strategic Translational Award and an Innovator Award from the Wellcome Trust (098983 & 209325); Science Foundation Ireland (15/RI/3239 and 15/SIRG/3580); and the Health Research Board, Ireland (NEPTuNE CDA‐2018‐008). Funders had no role in the design and conduct of the study or in this analysis. Funding Information: The authors would like to thank to all the families for their participation and to all the clinical and research teams at each recruiting for all their hard work and dedication. Open access funding provided by IReL. ANSER Consortium: INFANT Research Centre and Department of Pediatrics and Child Health, University College Cork, Cork, Ireland: Andreea M. Pavel, MD; Eugene M. Dempsey, MD; Vicki Livingstone, PhD; Elena Pavlidis, MD; Liudmila Kharoshankaya, MD; Sean R. Mathieson, PhD; William P. Marnane, PhD; Gordon Lightbody, PhD; Jackie O'Leary, MSc; Mairead Murray, MSc; Jean Conway, MSC; Denis Dwyer, BSc; Andrey Temko, PhD; Taragh Kiely, MSc; Anthony C. Ryan, MD; Geraldine B. Boylan, PhD. Institute for Women's Health, University College London, London, UK: Janet M. Rennie, MD; Subhabrata Mitra, PhD. Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, The Netherlands: Linda S. de Vries, PhD; Lauren C. Weeke, PhD; Mona C. Toet, PhD; Johanneke C. Harteman, PhD. Department of Neonatal Medicine and Division of Pediatrics, Department CLINTEC, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden: Mikael Finder, PhD; Mats Blennow, PhD; Ingela Edqvist. Rotunda Hospital, Dublin, Ireland: Adrienne Foran, MD; Raga Mallika Pinnamaneni, MD; Jessica Colby-Milley, MSc. Royal London Hospital and Queen Mary University of London, London, UK: Divyen K. Shah, MD; Nicola Openshaw-Lawrence. Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children NHS Trust, London, UK: Ronit M. Pressler, PhD. Homerton University Hospital NHS Foundation Trust, London, UK: Olga Kapellou, MD. Clinical Neurophysiology, University Medical Center Utrecht, Utrecht, The Netherlands: Alexander C. van Huffelen, PhD. Publisher Copyright: © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
(Peer reviewed)